Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) after 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals

  • James N. Moy
  • , Mark Anderson
  • , Xiaoying Shen
  • , Jia Fu
  • , Michael Stec
  • , Amy Gosha
  • , Dina Naquiallah
  • , Jennifer Kinslow
  • , David C. Montefiori
  • , Gavin Cloherty
  • , Alan Landay

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) after 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology